AAAAAA

   
Results: 1-25 | 26-50 | 51-60
Results: 1-25/60
YOUNG ONSET OF PRIMARY SJOGRENS-SYNDROME - CLINICAL AND IMMUNOLOGICALCHARACTERISTICS
Authors: RAMOSCASALS M CERVERA R FONT J GARCIACARRASCO M ESPINOSA G REINO S PALLARES L INGELMO M
Citation: M. Ramoscasals et al., YOUNG ONSET OF PRIMARY SJOGRENS-SYNDROME - CLINICAL AND IMMUNOLOGICALCHARACTERISTICS, Lupus, 7(3), 1998, pp. 202-206
FULMINANT THROMBOTIC THROMBOCYTOPENIC PURPURA IN SYSTEMIC LUPUS-ERYTHEMATOSUS
Authors: JORFEN M CALLEJAS JL FORMIGA F CERVERA R FONT J INGELMO M
Citation: M. Jorfen et al., FULMINANT THROMBOTIC THROMBOCYTOPENIC PURPURA IN SYSTEMIC LUPUS-ERYTHEMATOSUS, Scandinavian journal of rheumatology, 27(1), 1998, pp. 76-77
LACK OF CORRELATION BETWEEN TUMOR-MARKERS (CA-125 AND SCC) AND SYSTEMIC LUPUS-ERYTHEMATOSUS ACTIVITY
Authors: MIRET C FONT J MOLINA R FILELLA X VIVANCOS J MUNOZRODRIGUEZ FJ CERVERA R BALLESTA AM INGELMO M
Citation: C. Miret et al., LACK OF CORRELATION BETWEEN TUMOR-MARKERS (CA-125 AND SCC) AND SYSTEMIC LUPUS-ERYTHEMATOSUS ACTIVITY, Anticancer research, 18(2B), 1998, pp. 1341-1344
CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME - CLINICAL AND LABORATORY FEATURES OF 50 PATIENTS
Authors: ASHERSON RA CERVERA R PIETTE JC FONT J LIE JT BURCOGLU A LIM K MUNOZRODRIGUEZ FJ LEVY RA BOUE F ROSSERT J INGELMO M
Citation: Ra. Asherson et al., CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME - CLINICAL AND LABORATORY FEATURES OF 50 PATIENTS, Medicine, 77(3), 1998, pp. 195-207
ANTI-PROTHROMBIN ANTIBODIES IN PATIENTS WITH THE ANTIPHOSPHOLIPID SYNDROME
Authors: REVERTER JC MUNOZ FJ TASSIES D FONT J CERVERA R LOPEZSOTO A ESCOLAR G INGELMO M ORDINAS A
Citation: Jc. Reverter et al., ANTI-PROTHROMBIN ANTIBODIES IN PATIENTS WITH THE ANTIPHOSPHOLIPID SYNDROME, British Journal of Haematology, 102(1), 1998, pp. 249-249
INCREASED SERUM LEVELS OF SOLUBLE L-SELECTIN IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS-ERYTHEMATOSUS
Authors: RAMOSCASALS M FONT J PIZCUETA P CERVERA R GARCIACARRASCO M NAVARRO M JIMENEZ S INGELMO M ENGELS P
Citation: M. Ramoscasals et al., INCREASED SERUM LEVELS OF SOLUBLE L-SELECTIN IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS-ERYTHEMATOSUS, Arthritis and rheumatism, 41(9), 1998, pp. 246-246
ANTIPHOSPHOLIPID SYNDROME - LONG-TERM FOLLOW-UP PROSPECTIVE-STUDY OF A SERIES OF 75 PATIENTS
Authors: FONT J MUNOZRODRIGUEZ FJ CERVERA R REVERTER JC LOPEZSOTO A CARMONA F BALASCH J INGELMO M
Citation: J. Font et al., ANTIPHOSPHOLIPID SYNDROME - LONG-TERM FOLLOW-UP PROSPECTIVE-STUDY OF A SERIES OF 75 PATIENTS, Arthritis and rheumatism, 41(9), 1998, pp. 809-809
THE EFFECT OF 3 HUMAN MONOCLONAL ANTIPHOSPHOLIPID ANTIBODIES IN PLATELET INTERACTION WITH A COLLAGEN RICH SURFACE UNDER FLOW CONDITIONS IS BETA-2-GLYCOPROTEIN-I DEPENDENT
Authors: FONT J REVERTER JC KHAMASHTA MA TASSIES D CERVERA R ICHIKAWA K MONTEAGUDO J ESCOLAR G RAMOSCASALS M MUNOZ FJ HUGHES GRV ORDINAS A INGELMO M
Citation: J. Font et al., THE EFFECT OF 3 HUMAN MONOCLONAL ANTIPHOSPHOLIPID ANTIBODIES IN PLATELET INTERACTION WITH A COLLAGEN RICH SURFACE UNDER FLOW CONDITIONS IS BETA-2-GLYCOPROTEIN-I DEPENDENT, Arthritis and rheumatism, 41(9), 1998, pp. 810-810
ANTI-PROTHROMBIN ANTIBODIES IN PATIENTS WITH THE ANTIPHOSPHOLIPID SYNDROME
Authors: MUNOZ FJ FONT J REVERTER JC TASSIES D CERVERA R RAMOSCASALS M GARCIACARRASCO M ESPINOSA G ORDINAS A INGELMO M
Citation: Fj. Munoz et al., ANTI-PROTHROMBIN ANTIBODIES IN PATIENTS WITH THE ANTIPHOSPHOLIPID SYNDROME, Arthritis and rheumatism, 41(9), 1998, pp. 825-825
INFLUENCE OF NEPHROPATHY IN THE OUTCOME OF LUPUS PREGNANCY - A COMPARATIVE-STUDY
Authors: FONT J CARMONA F CERVERA R RAMOSCASALS M MUNOZ FJ CAYUELA MI JIMENEZ S CARARACH V INGELMO M
Citation: J. Font et al., INFLUENCE OF NEPHROPATHY IN THE OUTCOME OF LUPUS PREGNANCY - A COMPARATIVE-STUDY, Arthritis and rheumatism, 41(9), 1998, pp. 1491-1491
THE LONG-TERM OUTCOME OF LUPUS NEPHRITIS - STUDY OF 53 PATIENTS FOLLOWED MORE THAN 10 YEARS IN A SINGLE-CENTER
Authors: FONT J CERVERA R RAMOSCASALS M NONELL F JIMENEZ S TREJO O TORRAS A INGELMO M DARNELL A
Citation: J. Font et al., THE LONG-TERM OUTCOME OF LUPUS NEPHRITIS - STUDY OF 53 PATIENTS FOLLOWED MORE THAN 10 YEARS IN A SINGLE-CENTER, Arthritis and rheumatism, 41(9), 1998, pp. 1492-1492
CYTOPENIA AND PAST HUMAN PARVOVIRUS B19 INFECTION IN PATIENTS WITH PRIMARY SJOGRENS-SYNDROME
Authors: GARCIACARRASCO M CERVERA R VIDAL J RAMOSCASSALS M TREJO O JIMENEZ S DELARED G SISO A FONT J INGELMO M
Citation: M. Garciacarrasco et al., CYTOPENIA AND PAST HUMAN PARVOVIRUS B19 INFECTION IN PATIENTS WITH PRIMARY SJOGRENS-SYNDROME, Arthritis and rheumatism, 41(9), 1998, pp. 1765-1765
PRIMARY SJOGRENS-SYNDROME - CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS IN A SERIES OF 210 PATIENTS
Authors: GARCIACARRASCO M RAMOSCASALS M ROSAS J JIMENEZ S TREJO O DELARED G CERVERA R FONT J INGELMO M
Citation: M. Garciacarrasco et al., PRIMARY SJOGRENS-SYNDROME - CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS IN A SERIES OF 210 PATIENTS, Arthritis and rheumatism, 41(9), 1998, pp. 1766-1766
SUBCLINICAL THYROID-DISEASE IN PATIENTS WITH PRIMARY SJOGRENS-SYNDROME - ANALYSIS OF 130 PATIENTS WITHOUT PREVIOUS EVIDENCE OF THYROID INVOLVEMENT
Authors: RAMOSCASALS M CERVERA R GAYA J GARCIACARRASCO M MORLA RM TREJO O DELARED G FONT J INGELMO M
Citation: M. Ramoscasals et al., SUBCLINICAL THYROID-DISEASE IN PATIENTS WITH PRIMARY SJOGRENS-SYNDROME - ANALYSIS OF 130 PATIENTS WITHOUT PREVIOUS EVIDENCE OF THYROID INVOLVEMENT, Arthritis and rheumatism, 41(9), 1998, pp. 1773-1773
EFFECTS OF HUMAN MONOCLONAL ANTICARDIOLIPIN ANTIBODIES ON PLATELET-FUNCTION AND ON TISSUE FACTOR EXPRESSION ON MONOCYTES
Authors: REVERTER JC TASSIES D FONT J KHAMASHTA MA ICHIKAWA K CERVERA R ESCOLAR G HUGHES GRV INGELMO M ORDINAS A
Citation: Jc. Reverter et al., EFFECTS OF HUMAN MONOCLONAL ANTICARDIOLIPIN ANTIBODIES ON PLATELET-FUNCTION AND ON TISSUE FACTOR EXPRESSION ON MONOCYTES, Arthritis and rheumatism, 41(8), 1998, pp. 1420-1427
SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) IN CHILDHOOD - ANALYSIS OF CLINICAL AND IMMUNOLOGICAL FINDINGS IN 34 PATIENTS AND COMPARISON WITH SLE CHARACTERISTICS IN ADULTS
Authors: FONT J CERVERA R ESPINOSA G PALLARES L RAMOSCASALS M JIMENEZ S GARCIACARRASCO M SEISDEDOS L INGELMO M
Citation: J. Font et al., SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) IN CHILDHOOD - ANALYSIS OF CLINICAL AND IMMUNOLOGICAL FINDINGS IN 34 PATIENTS AND COMPARISON WITH SLE CHARACTERISTICS IN ADULTS, Annals of the Rheumatic Diseases, 57(8), 1998, pp. 456-459
HEPATITIS-G VIRUS-INFECTION IN PRIMARY SJOGRENS-SYNDROME - ANALYSIS IN A SERIES OF 100 PATIENTS
Authors: FONT J TASSIES D GARCIACARRASCO M RAMOSCASALS M CERVERA R REVERTER JC SANCHEZTAPIAS J MAZZARA R INGELMO M
Citation: J. Font et al., HEPATITIS-G VIRUS-INFECTION IN PRIMARY SJOGRENS-SYNDROME - ANALYSIS IN A SERIES OF 100 PATIENTS, Annals of the Rheumatic Diseases, 57(1), 1998, pp. 42-44
ANTIENDOTHELIAL CELL ANTIBODIES IN SYSTEMIC AUTOIMMUNE-DISEASES - PREVALENCE AND CLINICAL-SIGNIFICANCE
Authors: NAVARRO M CERVERA R FONT J REVERTER JC MONTEAGUDO J ESCOLAR G LOPEZSOTO A ORDINAS A INGELMO M
Citation: M. Navarro et al., ANTIENDOTHELIAL CELL ANTIBODIES IN SYSTEMIC AUTOIMMUNE-DISEASES - PREVALENCE AND CLINICAL-SIGNIFICANCE, Lupus, 6(6), 1997, pp. 521-526
SHRINKING LUNGS SYNDROME IN SYSTEMIC LUPUS-ERYTHEMATOSUS - IMPROVEMENT WITH INHALED BETA-AGONIST THERAPY
Authors: MUNOZRODRIGUEZ FJ FONT J BADIA JR MIRET C BARBERA JA CERVERA R INGELMO M
Citation: Fj. Munozrodriguez et al., SHRINKING LUNGS SYNDROME IN SYSTEMIC LUPUS-ERYTHEMATOSUS - IMPROVEMENT WITH INHALED BETA-AGONIST THERAPY, Lupus, 6(4), 1997, pp. 412-414
PRIMARY ANTIPHOSPHOLIPID SYNDROME EVOLVING INTO SYSTEMIC LUPUS-ERYTHEMATOSUS
Authors: SEISDEDOS L MUNOZRODRIGUEZ FJ CERVERA R FONT J INGELMO M
Citation: L. Seisdedos et al., PRIMARY ANTIPHOSPHOLIPID SYNDROME EVOLVING INTO SYSTEMIC LUPUS-ERYTHEMATOSUS, Lupus, 6(3), 1997, pp. 285-286
OPTIC NEUROPATHY IN THE PRIMARY ANTIPHOSPHOLIPID SYNDROME - REPORT OFA CASE AND REVIEW OF THE LITERATURE
Authors: REINO S MUNOZRODRIGUEZ FJ CERVERA R ESPINOSA G FONT J INGELMO M
Citation: S. Reino et al., OPTIC NEUROPATHY IN THE PRIMARY ANTIPHOSPHOLIPID SYNDROME - REPORT OFA CASE AND REVIEW OF THE LITERATURE, Clinical rheumatology, 16(6), 1997, pp. 629-631
ANTIPHOSPHOLIPID SYNDROME WITHOUT ANTIPHOSPHOLIPID ANTIBODIES AT THE TIME OF THE THROMBOTIC EVENT - TRANSIENT SERONEGATIVE ANTIPHOSPHOLIPIDSYNDROME
Authors: MIRET C CERVERA R REVERTER JC GARCIACARRASCO M RAMOS M MOLLA M FONT J INGELMO M
Citation: C. Miret et al., ANTIPHOSPHOLIPID SYNDROME WITHOUT ANTIPHOSPHOLIPID ANTIBODIES AT THE TIME OF THE THROMBOTIC EVENT - TRANSIENT SERONEGATIVE ANTIPHOSPHOLIPIDSYNDROME, Clinical and experimental rheumatology, 15(5), 1997, pp. 541-544
ANTIPHOSPHOLIPID ANTIBODIES IN PRIMARY SJOGRENS-SYNDROME - PREVALENCEAND CLINICAL-SIGNIFICANCE IN A SERIES OF 80 PATIENTS
Authors: CERVERA R GARCIACARRASCO M FONT J RAMOS M REVERTER JC MUNOZ FJ MIRET C ESPINOSA G INGELMO M
Citation: R. Cervera et al., ANTIPHOSPHOLIPID ANTIBODIES IN PRIMARY SJOGRENS-SYNDROME - PREVALENCEAND CLINICAL-SIGNIFICANCE IN A SERIES OF 80 PATIENTS, Clinical and experimental rheumatology, 15(4), 1997, pp. 361-365
ISOTYPE DISTRIBUTION AND CLINICAL-SIGNIFICANCE OF ANTIBODIES TO CARDIOLIPIN, PHOSPHATIDIC-ACID, PHOSPHATIDYLINOSITOL AND PHOSPHATIDYLSERINEIN SYSTEMIC LUPUS-ERYTHEMATOSUS - PROSPECTIVE ANALYSIS OF A SERIES OF92 PATIENTS
Authors: LOPEZSOTO A CERVERA R FONT J BOVE A REVERTER JC MUNOZ FJ MIRET C ESPINOSA G ORDINAS A INGELMO M
Citation: A. Lopezsoto et al., ISOTYPE DISTRIBUTION AND CLINICAL-SIGNIFICANCE OF ANTIBODIES TO CARDIOLIPIN, PHOSPHATIDIC-ACID, PHOSPHATIDYLINOSITOL AND PHOSPHATIDYLSERINEIN SYSTEMIC LUPUS-ERYTHEMATOSUS - PROSPECTIVE ANALYSIS OF A SERIES OF92 PATIENTS, Clinical and experimental rheumatology, 15(2), 1997, pp. 143-149
ANTI-BETA-2-GLYCOPROTEIN-I ANTIBODIES - A USEFUL MARKER FOR THE ANTIPHOSPHOLIPID SYNDROME
Authors: TEIXIDO M FONT J REVERTER JC CERVERA R TASSIES D INGELMO M ESCOLAR G ORDINAS A
Citation: M. Teixido et al., ANTI-BETA-2-GLYCOPROTEIN-I ANTIBODIES - A USEFUL MARKER FOR THE ANTIPHOSPHOLIPID SYNDROME, British journal of rheumatology, 36(1), 1997, pp. 113-116
Risultati: 1-25 | 26-50 | 51-60